StartUPDATES: New Developments from Healthcare Startups
Check out news from Equiva, First In Venture Studio, and Parallel Bio.
StartUPDATES: New developments from healthcare startups
Check out new developments from Carrum Health, Equiva, imaware, Elo, Paige, Gozio Health and WELL Health.
Changes in Nurse Staffing Answer Clinician Demands
The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.
StartUPDATES: New developments from healthcare startups
Check out new developments from Carrum Health, Equiva, Carefeed, Brain Check, and Atropos Health.
StartUPDATES: New developments from healthcare startups
Check out news from Equiva, Canvas Medical, Particle Health, Fold Health, and Nucleus Genomics.
StartUPDATES: New developments from healthcare startups
Check out news from Equiva, Vida Health, Canaery, and DocPanel.
StartUPDATES: New developments for healthcare startups
Check out new developments from Equiva, SonALAsense, Sensible Care, and more.
Tackling Rising Drug Costs and Growing Popularity of GLP-1’s
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.
StartUPDATES: New developments for healthcare startups
Check out news from Opala, Equiva, Sling Therapeutics, Quil, and Third Rock Ventures.
StartUPDATES: New developments from healthcare startups
Check out news from Equiva, PrecisionGx, Wavemaker Three-Sixty Health, Jasper Health, and Anagenex.
StartUPDATES: New developments from healthcare startups
Check out news from Memory Health, Equiva, KAID Health, Tegria, and Japa Health.
StartUPDATES: New developments for healthcare startups
Check out news from Equiva, Evernow, StationMD, Nurse 1-1, and more.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
StartUPDATES: New developments from healthcare startups
Check out news from Equiva, Healthmine, Recora, and Antidote Health.
StartUPDATES: New developments for healthcare startups
Read about news from Element Science, Healthmine, Equiva, UniDoc Health Corp., and House RX.
StartUPDATES: New developments from healthcare startups
Read about news from Equiva, Healthmine, Prenosis, 9am.health, and Socially Determined.
StartUPDATES: New developments from healthcare startups
Read about news from Equiva, Doceree, Verana Health and XR Health.
StartUPDATES: New developments from healthcare startups
Check out news from Equiva, Minded, Rightway and more.